Holdings
38
Concentrated
Top 10 weight
58%
Concentration
Active share
-
Style
Equity
98%
Asset allocation
Portfolio
-Sectors
6High-conviction bets
-Top sector wt.
0.0%Cash
Market-cap allocation
Large cap40%
Mid cap27%
Small cap31%
Asset allocation
Equity98%
Top holdings
12.8%
Lupin LimitedEQUITY
7.5%6.7%
Cipla LimitedEQUITY
6.2%5.5%
5.3%
Mankind Pharma LimitedEQUITY
4.0%3.5%
Ajanta Pharma LimitedEQUITY
3.5%3.3%
3.2%
2.8%
2.7%
2.6%
2.5%
Triparty RepoCASH_EQUIVALENT
2.3%Gland Pharma LimitedEQUITY
2.2%Abbott India LimitedEQUITY
2.1%2.0%
1.9%
1.8%
Aurobindo Pharma LimitedEQUITY
1.8%1.7%
Pfizer LimitedEQUITY
1.6%1.5%
1.4%
1.2%
1.1%
1.0%
Piramal Pharma LimitedEQUITY
1.0%0.9%
Sanofi India LimitedEQUITY
0.9%Biocon LimitedEQUITY
0.7%0.6%
Indoco Remedies LimitedEQUITY
0.5%Concord Biotech LimitedEQUITY
0.2%Net Current AssetsCASH_EQUIVALENT
0.1%Cash Margin - CCILCASH_EQUIVALENT
0.0%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- No major structural red flags.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
72.5%
22.0%
3.2%